FORTREA HOLDINGS INC (FTRE) Fundamental Analysis & Valuation

NASDAQ:FTRE • US34965K1079

Current stock price

12.18 USD
+0.68 (+5.91%)
At close:
12.18 USD
0 (0%)
After Hours:

This FTRE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. FTRE Profitability Analysis

1.1 Basic Checks

  • In the past year FTRE was profitable.
  • FTRE had a positive operating cash flow in the past year.
  • In multiple years FTRE reported negative net income over the last 5 years.
  • FTRE had a positive operating cash flow in each of the past 5 years.
FTRE Yearly Net Income VS EBIT VS OCF VS FCFFTRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M -800M

1.2 Ratios

  • FTRE has a Return On Assets of -36.31%. This is amonst the worse of the industry: FTRE underperforms 82.46% of its industry peers.
  • FTRE's Return On Equity of -175.01% is on the low side compared to the rest of the industry. FTRE is outperformed by 85.96% of its industry peers.
Industry RankSector Rank
ROA -36.31%
ROE -175.01%
ROIC N/A
ROA(3y)-15.36%
ROA(5y)-7.87%
ROE(3y)-66.87%
ROE(5y)-38.36%
ROIC(3y)N/A
ROIC(5y)N/A
FTRE Yearly ROA, ROE, ROICFTRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

  • FTRE's Gross Margin of 18.50% is on the low side compared to the rest of the industry. FTRE is outperformed by 84.21% of its industry peers.
  • FTRE's Gross Margin has been stable in the last couple of years.
  • FTRE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.07%
GM growth 5Y-0.49%
FTRE Yearly Profit, Operating, Gross MarginsFTRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 -30

0

2. FTRE Health Analysis

2.1 Basic Checks

  • FTRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for FTRE has been increased compared to 1 year ago.
  • The number of shares outstanding for FTRE has been increased compared to 5 years ago.
  • Compared to 1 year ago, FTRE has a worse debt to assets ratio.
FTRE Yearly Shares OutstandingFTRE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
FTRE Yearly Total Debt VS Total AssetsFTRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of 0.55, we must say that FTRE is in the distress zone and has some risk of bankruptcy.
  • FTRE's Altman-Z score of 0.55 is on the low side compared to the rest of the industry. FTRE is outperformed by 63.16% of its industry peers.
  • FTRE has a debt to FCF ratio of 11.92. This is a negative value and a sign of low solvency as FTRE would need 11.92 years to pay back of all of its debts.
  • FTRE's Debt to FCF ratio of 11.92 is in line compared to the rest of the industry. FTRE outperforms 57.89% of its industry peers.
  • FTRE has a Debt/Equity ratio of 1.86. This is a high value indicating a heavy dependency on external financing.
  • FTRE has a worse Debt to Equity ratio (1.86) than 80.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.86
Debt/FCF 11.92
Altman-Z 0.55
ROIC/WACCN/A
WACC11.4%
FTRE Yearly LT Debt VS Equity VS FCFFTRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • FTRE has a Current Ratio of 0.98. This is a bad value and indicates that FTRE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of FTRE (0.98) is worse than 87.72% of its industry peers.
  • A Quick Ratio of 0.98 indicates that FTRE may have some problems paying its short term obligations.
  • The Quick ratio of FTRE (0.98) is worse than 82.46% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
FTRE Yearly Current Assets VS Current LiabilitesFTRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

5

3. FTRE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 23.53% over the past year.
  • The Revenue has been growing slightly by 1.00% in the past year.
  • Measured over the past years, FTRE shows a small growth in Revenue. The Revenue has been growing by 1.09% on average per year.
EPS 1Y (TTM)23.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)1%
Revenue growth 3Y-4.19%
Revenue growth 5Y1.09%
Sales Q2Q%-5.24%

3.2 Future

  • FTRE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.11% yearly.
  • FTRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.33% yearly.
EPS Next Y65.96%
EPS Next 2Y48.95%
EPS Next 3Y43.42%
EPS Next 5Y37.11%
Revenue Next Year-4.74%
Revenue Next 2Y-0.9%
Revenue Next 3Y1.1%
Revenue Next 5Y2.33%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FTRE Yearly Revenue VS EstimatesFTRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B
FTRE Yearly EPS VS EstimatesFTRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1 2 3 4

6

4. FTRE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 29.00 indicates a quite expensive valuation of FTRE.
  • Compared to the rest of the industry, the Price/Earnings ratio of FTRE indicates a somewhat cheap valuation: FTRE is cheaper than 73.68% of the companies listed in the same industry.
  • FTRE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.64.
  • With a Price/Forward Earnings ratio of 17.47, FTRE is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, FTRE is valued cheaply inside the industry as 87.72% of the companies are valued more expensively.
  • FTRE's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.36.
Industry RankSector Rank
PE 29
Fwd PE 17.47
FTRE Price Earnings VS Forward Price EarningsFTRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • FTRE's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, FTRE is valued cheaper than 92.98% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.9
EV/EBITDA 41.21
FTRE Per share dataFTRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

  • FTRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • FTRE's earnings are expected to grow with 43.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.44
PEG (5Y)N/A
EPS Next 2Y48.95%
EPS Next 3Y43.42%

0

5. FTRE Dividend Analysis

5.1 Amount

  • FTRE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

FTRE Fundamentals: All Metrics, Ratios and Statistics

FORTREA HOLDINGS INC

NASDAQ:FTRE (5/1/2026, 8:00:01 PM)

After market: 12.18 0 (0%)

12.18

+0.68 (+5.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Industry Strength20.5
Industry Growth50.31
Earnings (Last)02-26
Earnings (Next)05-05
Inst Owners103.61%
Inst Owner Change0.15%
Ins Owners0.38%
Ins Owner Change7.44%
Market Cap1.14B
Revenue(TTM)2.72B
Net Income(TTM)-986.20M
Analysts75.29
Price Target14.64 (20.2%)
Short Float %11.38%
Short Ratio7.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-33.22%
Min EPS beat(2)-44.92%
Max EPS beat(2)-21.52%
EPS beat(4)2
Avg EPS beat(4)64.45%
Min EPS beat(4)-44.92%
Max EPS beat(4)197.56%
EPS beat(8)2
Avg EPS beat(8)-68.39%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.74%
Min Revenue beat(2)-2.66%
Max Revenue beat(2)6.15%
Revenue beat(4)3
Avg Revenue beat(4)4.77%
Min Revenue beat(4)-2.66%
Max Revenue beat(4)10.63%
Revenue beat(8)3
Avg Revenue beat(8)-0.68%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.58%
PT rev (3m)-5.59%
EPS NQ rev (1m)-27.35%
EPS NQ rev (3m)-62.07%
EPS NY rev (1m)-12.46%
EPS NY rev (3m)-12.6%
Revenue NQ rev (1m)-1.87%
Revenue NQ rev (3m)-4.64%
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-4.98%
Valuation
Industry RankSector Rank
PE 29
Fwd PE 17.47
P/S 0.42
P/FCF 12.9
P/OCF 10.03
P/B 2.02
P/tB N/A
EV/EBITDA 41.21
EPS(TTM)0.42
EY3.45%
EPS(NY)0.7
Fwd EY5.72%
FCF(TTM)0.94
FCFY7.75%
OCF(TTM)1.21
OCFY9.97%
SpS29.13
BVpS6.03
TBVpS-10.89
PEG (NY)0.44
PEG (5Y)N/A
Graham Number7.5467 (-38.04%)
Profitability
Industry RankSector Rank
ROA -36.31%
ROE -175.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.5%
FCFM 3.24%
ROA(3y)-15.36%
ROA(5y)-7.87%
ROE(3y)-66.87%
ROE(5y)-38.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.07%
GM growth 5Y-0.49%
F-Score3
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 1.86
Debt/FCF 11.92
Debt/EBITDA 22.11
Cap/Depr 32.31%
Cap/Sales 0.93%
Interest Coverage N/A
Cash Conversion 239.45%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 0.55
F-Score3
WACC11.4%
ROIC/WACCN/A
Cap/Depr(3y)34.26%
Cap/Depr(5y)35.48%
Cap/Sales(3y)1.1%
Cap/Sales(5y)1.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y65.96%
EPS Next 2Y48.95%
EPS Next 3Y43.42%
EPS Next 5Y37.11%
Revenue 1Y (TTM)1%
Revenue growth 3Y-4.19%
Revenue growth 5Y1.09%
Sales Q2Q%-5.24%
Revenue Next Year-4.74%
Revenue Next 2Y-0.9%
Revenue Next 3Y1.1%
Revenue Next 5Y2.33%
EBIT growth 1Y72.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.04%
EBIT Next 3Y20.04%
EBIT Next 5Y17.77%
FCF growth 1Y-62.79%
FCF growth 3Y38.69%
FCF growth 5Y-12.97%
OCF growth 1Y-56.81%
OCF growth 3Y9.06%
OCF growth 5Y-10.79%

FORTREA HOLDINGS INC / FTRE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of FORTREA HOLDINGS INC (FTRE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to FTRE.


What is the valuation status for FTRE stock?

ChartMill assigns a valuation rating of 6 / 10 to FORTREA HOLDINGS INC (FTRE). This can be considered as Fairly Valued.


How profitable is FORTREA HOLDINGS INC (FTRE) stock?

FORTREA HOLDINGS INC (FTRE) has a profitability rating of 2 / 10.


How financially healthy is FORTREA HOLDINGS INC?

The financial health rating of FORTREA HOLDINGS INC (FTRE) is 0 / 10.


Can you provide the expected EPS growth for FTRE stock?

The Earnings per Share (EPS) of FORTREA HOLDINGS INC (FTRE) is expected to grow by 65.96% in the next year.